Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 40.509 a 40.528 di 46.112
Titolo Data di pubblicazione Autore(i) File
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 1-gen-2022 Montorsi, Francesco; Mazzone, Elio; Gandaglia, Giorgio; Stabile, Armando; Salonia, Andrea; Briganti, Alberto
Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma 1-gen-2019 Buettner, S.; ten Cate, D. W. G.; Bagante, F.; Alexandrescu, S.; Marques, H. P.; Lamelas, J.; Aldrighetti, L.; Gamblin, T. C.; Maithel, S. K.; Pulitano, C.; Margonis, G. A.; Weiss, M.; Bauer, T. W.; Shen, F.; Poultsides, G. A.; Marsh, J. W.; Ijzermans, J. N. M.; Pawlik, T. M.; Koerkamp, B. G.
Survival after T cell depleted haploidentical stem cell transplantation is improved using the mother as donor 1-gen-2008 Stern, M; Ruggeri, L; Mancusi, A; Bernardo, M; DE ANGELIS, C; Bucher, C; Locatelli, F; Aversa, F; Velardi, A
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 1-gen-2019 Palumbo, C.; Pecoraro, A.; Knipper, S.; Rosiello, G.; Tian, Z.; Shariat, S. F.; Simeone, C.; Briganti, A.; Saad, F.; Berruti, A.; Antonelli, A.; Karakiewicz, P. I.
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis 1-gen-2017 Ammirati, Enrico; Cipriani, Manlio; Lilliu, Marzia; Sormani, Paola; Varrenti, Marisa; Raineri, Claudia; Petrella, Duccio; Garascia, Andrea; Pedrotti, Patrizia; Roghi, Alberto; Bonacina, Edgardo; Moreo, Antonella; Bottiroli, Maurizio; Gagliardone, Maria P.; Mondino, Michele; Ghio, Stefano; Totaro, Rossana; Turazza, Fabio M.; Russo, Claudio F.; Oliva, Fabrizio; Camici, Paolo; Frigerio, Maria
Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium 1-gen-2021 Beyer, J.; Collette, L.; Sauve, N.; Daugaard, G.; Feldman, D. R.; Tandstad, T.; Tryakin, A.; Stahl, O.; Gonzalez-Billalabeitia, E.; de Giorgi, U.; Culine, S.; de Wit, R.; Hansen, A. R.; Bebek, M.; Terbuch, A.; Albany, C.; Hentrich, M.; Gietema, J. A.; Negaard, H.; Huddart, R. A.; Lorch, A.; Cafferty, F. H.; Heng, D. Y. C.; Sweeney, C. J.; Winquist, E.; Chovanec, M.; Fankhauser, C.; Stark, D.; Grimison, P.; Necchi, A.; Tran, B.; Heidenreich, A.; Shamash, J.; Sternberg, C. N.; Vaughn, D. J.; Duran, I.; Bokemeyer, C.; Patrikidou, A.; Cathomas, R.; Assele, S.; Gillessen, S.
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 1-gen-2017 Cingolani, Antonella; Lepri, Alessandro Cozzi; Teofili, Luciana; Galli, Laura; Mazzotta, Valentina; Baldin, Gian Maria; Hohaus, Stefan; Bandera, Alessandra; Alba, Lucia; Galizzi, Nadia; Castagna, Antonella; D’arminio Monforte, Antonella; Antinori, Andrea
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis 1-gen-2014 Gandaglia, G; Sun, M; Trinh, Qd; Becker, A; Schiffmann, J; Hu, Jc; Briganti, Alberto; Montorsi, Francesco; Perrotte, P; Karakiewicz, Pi; Abdollah, F.
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 1-gen-2015 Vitale, A.; Burra, P.; Frigo, A. C.; Trevisani, F.; Farinati, F.; Spolverato, G.; Volk, M.; Giannini, E. G.; Ciccarese, F.; Piscaglia, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Cabibbo, G.; Felder, M.; Gasbarrini, A.; Sacco, R.; Foschi, F. G.; Missale, G.; Morisco, F.; Svegliati Baroni, G.; Virdone, R.; Cillo, U; Olmi, S; on behalf of Italian Liver Cancer, (ITA. LI. CA) group.
Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages 1-gen-2018 Pompe, Raisa S; Tilki, Derya; Preisser, Felix; Leyh-Bannurah, Sami-Ramzi; Bandini, Marco; Marchioni, Michele; Gild, Philipp; Tian, Zhe; Fossati, Nicola; Cindolo, Luca; Shariat, Shahrokh F; Huland, Hartwig; Graefen, Markus; Briganti, Alberto; Karakiewicz, Pierre I
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics 1-gen-2012 Abdollah, Firas; Sun, Maxine; Schmitges, Jan; Thuret, Rodolphe; Bianchi, Marco; Shariat Shahrokh, F.; Briganti, Alberto; Jeldres, Claudio; Perrotte, Paul; Montorsi, Francesco; Karakiewicz Pierre, I.
Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis 1-gen-2017 Wolff, G; Dimitroulis, D; Andreotti, F; Kolodziejczak, M; Jung, C; Scicchitano, P; Devito, F; Zito, A; Occhipinti, M; Castiglioni, B; Calveri, G; Maisano, F; Ciccone, Mm; De Servi, S; Navarese, Ep
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 1-gen-2019 Nazzani, S.; Preisser, F.; Mazzone, E.; Marchioni, M.; Bandini, M.; Tian, Z.; Mistretta, F. A.; Shariat, S. F.; Soulieres, D.; Montanari, E.; Acquati, P.; Briganti, A.; Carmignani, L.; Karakiewicz, P. I.
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 1-gen-2019 Nazzani, S.; Preisser, F.; Mazzone, E.; Marchioni, M.; Bandini, M.; Tian, Z.; Mistretta, F. A.; Shariat, S. F.; Soulieres, D.; Saad, F.; Montanari, E.; Luzzago, S.; Briganti, A.; Carmignani, L.; Karakiewicz, P. I.
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 1-gen-2019 Nazzani, S.; Preisser, F.; Mazzone, E.; Tian, Z.; Mistretta, F. A.; Shariat, S. F.; Soulieres, D.; Saad, F.; Montanari, E.; Luzzago, S.; Briganti, A.; Carmignani, L.; Karakiewicz, P. I.
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma 1-gen-2006 Brandes, Aa; Nicolardi, L; Tosoni, A; Gardiman, M; Iuzzolino, P; Ghimenton, C; Reni, M; Rotilio, A; Sotti, G; Ermani, M
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma 1-gen-2006 Brandes, Aa; Nicolardi, L; Tosoni, A; Compostella, A; Roma, A; Blatt, V; Reni, M; Rotilio, A; Mottaran, R; Berti, F
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: The impact of competing causes of mortality and patient stratification 1-gen-2013 Abdollah, F; Boorjian, S; Cozzarini, C; Suardi, N; Sun, M; Fiorino, C; di Muzio, N; Karakiewicz, Pi; Montorsi, Francesco; Karnes, Rj; Briganti, Alberto
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer 1-gen-2017 Tosco, L.; Laenen, A.; Briganti, A.; Gontero, P.; Karnes, R. J.; Albersen, M.; Bastian, P. J.; Chlosta, P.; Claessens, F.; Chun, F. K.; Everaerts, W.; Gratzke, C.; Graefen, M.; Kneitz, B.; Marchioro, G.; Salas, R. S.; Tombal, B.; Van Den Broeck, T.; Moris, L.; Battaglia, A.; Van Der Poel, H.; Walz, J.; Bossi, A.; De Meerleer, G.; Haustermans, K.; Van Poppel, H.; Spahn, M.; Joniau, S.
SURVIVAL IMPROVEMENT OF UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED INTENSITY REGIMENS IN HIGH-RISK PATIENTS FOR AGE OR DISEASE (ON BEHALF OF GITMO) 1-gen-2008 Rambaldi, A; Carobbio, A; Lombardini, L; Lamparelli, T; Pollichieni, S; Oneto, R; Fanin, R; Bonifazi, F; Corradini, P; Lambertenghi, G; Ciceri, Fabio; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Falda, M; Benedetti, F; Bacigalupo, A; Bosi, A.
Mostrati risultati da 40.509 a 40.528 di 46.112
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile